LEADER 01556nam a2200337 u 4500
001 EB001999318
003 EBX01000000000000001162219
005 00000000000000.0
007 tu|||||||||||||||||||||
008 210907 r ||| eng
020 |a 1587630400 
020 |a 9781587630408 
050 4 |a RC641 
100 1 |a Flamm, Carole Redding 
245 0 0 |a Use of epoetin for anemia in chronic renal failure  |h Elektronische Ressource  |c prepared for Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services ; prepared by Blue Cross and Blue Shield Association Technology Evaluation Center ; Carole Redding Flamm, principal investigator ; Naomi Aronson ... [et al.], investigators 
260 |a Rockville, Md.  |b The Agency  |c [2001], 2001 
300 |a viii, 201 p.  |b ill.  |c 28 cm 
505 0 |a Includes bibliographical references (p. 139-189) 
653 |a Erythropoietin / therapeutic use 
653 |a Anemia / drug therapy 
653 |a Kidney Failure, Chronic / complications 
653 |a Anemia / blood 
700 1 |a Aronson, Naomi 
710 2 |a United States  |b Agency for Healthcare Research and Quality 
710 2 |a Blue Cross and Blue Shield Association  |b Technology Evaluation Center 
041 0 7 |a eng  |2 ISO 639-2 
989 |b NCBI  |a National Center for Biotechnology Information 
490 0 |a Evidence report/technology assessment 
500 |a "August 2001.". - "Contract no. 290-97-0015." 
856 4 0 |u https://www.ncbi.nlm.nih.gov/books/NBK33568  |3 Volltext  |n NLM Bookshelf Books  |3 Volltext 
082 0 |a 610